COVID-19 vaccinemaker Novavax faces manufacturing setback – Science Magazine

Novavax, based in Gaithersburg, Maryland, announced a setback this week in its quest for U.S. Food and Drug Administration emergency use authorization of its COVID-19 vaccine.
Alyssa Schukar/Redux
By Meredith WadmanAug. 6, 2021 , 6:15 PM
Novavax, the small,…

Click here to view the original article.